Interindividual differences in response to chemoprotection against aflatoxin-induced hepatocarcinogenesis: Implications for human biotransformation enzyme polymorphisms

Advances in Experimental Medicine and Biology

Volumn 500, Issue , 2001, Pages 559-576

  Eaton, David L ^a   Bammler, Theo K ^a   Kelly, Edward J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; AFLATOXIN; AFLATOXIN 9.0 EPOXIDE; AFLATOXIN B1; AFLATOXIN M1; AFLATOXIN P1; AFLATOXIN Q1; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2A6; CYTOCHROME P450 2B; CYTOCHROME P450 3A4; GLUTATHIONE; GLUTATHIONE TRANSFERASE; LIVER PROTECTIVE AGENT; MYCOTOXIN; OLTIPRAZ; UNCLASSIFIED DRUG;

ASPERGILLUS FLAVUS; BIOTRANSFORMATION; CANCER PREVENTION; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; CONFERENCE PAPER; DRUG DETOXIFICATION; FOOD CONTAMINATION; HUMAN; INDIVIDUALITY; LIVER CANCER; LIVER CARCINOGENESIS; LIVER MICROSOME METABOLISM; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

ANIMALIA; ASPERGILLUS; ASPERGILLUS FLAVUS; LAMB;

EID: 0035700108     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0667-6_85     Document Type: Conference Paper

References (72)

1. Catalytic triad of microsomal epoxide hydrolase: Replacement of Glu404 with Asp leads to a strongly increased turnover rate
2. The role of mu-class glutathione S-transferases in the detoxification of aflatoxin B1-8,9-epoxide
3. 1 biotransformation in non-human primates
4. Aflatoxin B1 oxidation by human cytochromes P450 CYP1A1, 2A6, 2C8, 2C9, 2C18 and 2C19
5. Consumption of brussels sprouts results in elevated alpha-class glutathione S-transferase levels in human blood plasma
6. Mouse strain differences in glutathione S-transferase activity and aflatoxin B1 biotransformation
7. Complementary DNA cloning, messenger RNA expression, and induction of alpha-class glutathione S-transferases in mouse tissues
8. Oltipraz-mediated changes in aflatoxin B1 biotransformation n rat liver: Implications for human chemointervention
9. Induction of phase I and phase II drag metabolizing enzyme mRNA, protein and activity by BHA, ethoxyquin and oltipraz
10. Comparison of the aflatoxin B1-B8,9-epoxide conjugating activities of two bacterially expressed alpha class glutathione S-transferase isozymes from mouse and rat
11. The inhibitory effects of ethoxyquin on the carcinogenic action of aflatoxin B1 in rats
12. Activation and deactivation of aflatoxin B1 in isolated rat hepatocytes
13. Effect of inhibitors of microsomal enzymes on aflatoxin B1-induced cytotoxicity and inhibition of RNA synthesis in isolated rat hepatocytes
14. Concise review of the glutathione S-transferases and their significance to toxicology
15. Mechanisms of aflatoxin carcinogenesis
16. Role of Cytochrome P450 1A2 in chemical carcinogenesis: Implications for human variability in expression and enzyme activity
17. Saccharomyces cerevisiae: An alternative source for human microsomal liver enzymes and its use in drug interaction studies
18. The kinetics of aflatoxin B-1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4
19. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1
20. Radiometric assays for mammalian epoxide hydrolases and glutathione S-transferase
21. Human cytochrome P450 enzymes
22. Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer
23. Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent
24. Epidemiology of aflatoxin-related disease
25. Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants
26. Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin
27. Contribution of the glutathione S-transferases to the mechanisms of resistance to aflatoxin B1
28. Molecular cloning and heterologous expression of a cDNA encoding a mouse glutathione S-transferase Yc subunit possessing high catalytic activity for aflatoxin B1-8,9-epoxide
29. Cloning of cDNAs from fetal rat liver encoding glutathione S-transferase Yc polypeptides. The Yc2 subunit is expressed in adult rat liver resistant to the hepatocarcinogen aflatoxin B1
30. Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: Evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B-1 aldehyde reductase
31. DNA adduction by the potent carcinogen aflatoxin B1: Mechanistic studies
32. Kinetics and mechanism of hydrolysis of aflatoxin B-1 exo-8,9-epoxide and rearrangement of the dihydrodiol
33. Aflatoxin B-1 8,9-epoxide hydrolysis in the presence of rat and human epoxide hydrolase
34. A novel aldehyde reductase with activity towards a metabolite of aflatoxin B1 is expressed in rat liverduring carcinogenesis and following the administration of an anti-oxidant
35. Expression of human microsomal epoxide hydrolase protects against aflatoxin B1-induced genotoxicity in yeast co-expressing human CYP1A enzymes
36. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: Role of induction of glutathione S-transferases
37. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones
38. Oltipraz chemoprevention trial in Qidong, People's Republic of China: Modulation of serum aflatoxin albumin adduct biomarkers
39. Detoxication of aflatoxin B1 by glutathione transferase
40. cDNA cloning, expression and activity of a second human aflatoxin B 1-metabolizing member of the aldo-keto reductase superfamily,AKR7A3
41. Events in the induction of rat hepatic UDP-glucuronosyltransferases, glutathione S-transferase, and microsomal epoxide hydrolase by 1,7-phenanthroline: Comparison with oltipraz, tert-butyl-4-hydroxyanisole, and tert-butylhydroquinone
42. Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture
43. Biochemical and molecular aspects of mammalian susceptibility to aflatoxin B1 carcinogenicity
44. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1
45. Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and mouse
46. Effects of modulation of hepatic glutathione on biotransformation and covalent binding of aflatoxin B1 to DNA in the mouse
47. The metabolism of aflatoxin B1 by human liver
48. The mercapturic acid pathway metabolites of a glutathione conjugate of aflatoxin B1
49. 1 in human-derived in vitro systems
50. Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: A review
51. Effects of consumption of Brussels sprouts on intestinal and lymphocytic glutathione S-transferases in humans
52. Sequestration of biologgical reactive intermediates by trapping as covalent enzyme-intermediate complex
53. Activation of aflatoxin B1 by mouse CYP2A enzymes and cytotoxicity in recombinant yeast cells
54. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China
55. Bioactivation of aflatoxin B1 by human liver microsomes: Role of cytochrome P450 IIIA enzymes
56. The endo-8,9-epoxide of aflatoxin B1: A new metabolite
57. Glutathione conjugation of aflatoxin B1 exo- and endo-epoxides by rat and human glutathione S-transferases
58. Oxidation of aflatoxins and sterigmatocystin by human liver microsomes: Significance of aflatoxin Q1 as a detoxication product of aflatoxin B1
59. Subunit diversity and tissue distribution of human glutathione S-transferases: Interpretations based on electrospray ionization-MS and peptide sequence-specific antisera
60. Aflatoxin B1 epoxidation catalysed by partially purified human liver lipoxygenase
61. Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats
62. Identification of an aflatoxin G1-serum albumin adduct and its relevance to the measurement of human exposure to aflatoxins
63. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion
64. DNA recombination induced by aflatoxin B1 activated by cytochrome P450 1A enzymes
65. Human variability in hepatic glutathione S-transferase-mediated conjugation of aflatoxin B1-epoxide and other substrates
66. Enzymatic characteristic of chimeric mYc/rYC1 glutathione S-transferases
67. Identification of amino acid residues essential for high aflatoxin B1-B8 9-epoxide conjugation activity in Alpha class glutathione S-transferases through site-directed mutagenesis
68. Quantification of human hepatic glutathione S-transferases
69. Protective alterations in phase 1 and 2 metabolism of aflatoxin B-1 by oltipraz in residents of Qidong, People's Republic of China
70. Environmental and genetic determinants of aflatoxin-albumin adducts in the Gambia
71. Bioactivation and inactivation of aflatoxin B1 by human, mouse and rat liver preparations: Effect on SCE in human mononuclear leucocytes
72. Aflatoxin carcinogenesis